Phytomedicine in cancer therapy advances in plant-based secondary metabolites as chemopreventive agents

This research explores the role of plant-based secondary metabolites in cancer therapy, specifically their potential as chemopreventive agents. A comprehensive review of existing studies, clinical trials, and experimental data was conducted, focusing on the anticancer properties of secondary metabolites found in plants. The findings reveal that metabolites such as curcumin, epigallocatechin gallate (EGCG), and resveratrol exhibit significant chemopreventive potential, demonstrating effects on cancer cell apoptosis, inhibition of proliferation, and suppression of metastasis. These bioactive compounds target various molecular pathways, including oxidative stress modulation and inflammatory response regulation. The implications of these findings suggest that phytochemicals could be integrated into cancer prevention strategies and serve as complementary treatments alongside conventional therapies. Future research should focus on overcoming the challenges related to bioavailability, toxicity, and the need for further clinical trials to substantiate the therapeutic efficacy of these plant-based compounds.